nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis
|
Guedes, Ludmila Resende |
|
|
29 |
4 |
p. |
artikel |
2 |
Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis
|
Vega, Luis |
|
|
29 |
4 |
p. |
artikel |
3 |
Correspondence: “A multisociety Delphi consensus statement on new fatty liver disease nomenclature”
|
Wan, Kim Sui |
|
|
29 |
4 |
p. |
artikel |
4 |
Editorial board
|
|
|
|
29 |
4 |
p. |
artikel |
5 |
Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis
|
Malik, Adnan |
|
|
29 |
4 |
p. |
artikel |
6 |
From NAFLD to MASLD: Promise and pitfalls of a new definition
|
Cusi, Kenneth |
|
|
29 |
4 |
p. |
artikel |
7 |
Genome-wide DNA methylation and transcriptomic analysis of liver tissues subjected to early ischemia/reperfusion injury upon human liver transplantation
|
Giraudi, Pablo J. |
|
|
29 |
4 |
p. |
artikel |
8 |
Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis
|
Jeong, Hye-Won |
|
|
29 |
4 |
p. |
artikel |
9 |
Key points for imaging diagnosis and response assessment for hepatocellular carcinoma in Latin America
|
Telli, Federico Diaz |
|
|
29 |
4 |
p. |
artikel |
10 |
Liver fibrosis: More than meets the eye
|
Lonardo, Amedeo |
|
|
29 |
4 |
p. |
artikel |
11 |
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
|
Patel, Ankoor H. |
|
|
29 |
4 |
p. |
artikel |
12 |
Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights
|
Nakamura, Atsushi |
|
|
29 |
4 |
p. |
artikel |
13 |
Protean strictures: Shifting severity beneath the diagnostic façade
|
Bazerbachi, Fateh |
|
|
29 |
4 |
p. |
artikel |
14 |
Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis?
|
Agoglia, Luciana |
|
|
29 |
4 |
p. |
artikel |
15 |
Reply to: “From NAFLD to MASLD: Promise and pitfalls of a new definition’
|
Rinella, Mary E. |
|
|
29 |
4 |
p. |
artikel |
16 |
Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: A cross-sectional study based on the national health and nutrition examination survey data
|
Li, Jinze |
|
|
29 |
4 |
p. |
artikel |
17 |
Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021
|
Congly, Stephen E. |
|
|
29 |
4 |
p. |
artikel |
18 |
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
|
Barrera, Francisco |
|
|
29 |
4 |
p. |
artikel |
19 |
Utilizing a novel MRI technique to identify adverse muscle composition in end-stage liver disease: A pilot study
|
Thuluvath, Avesh J. |
|
|
29 |
4 |
p. |
artikel |
20 |
ZBP1 promotes hepatocyte pyroptosis in acute liver injury by regulating the PGAM5/ROS pathway
|
Yan, Shengguang |
|
|
29 |
4 |
p. |
artikel |